Surface Oncology

PharmaceuticalsSeries ACambridge, USsurfaceoncology.com

Latest round

Series A

Last raised

Jan 2015

Total raised

$24M

Investors

6

About Surface Oncology

Surface Oncology, Inc.Founded in 2014 and headquartered in Cambridge, US, Surface Oncology, Inc. specializes in advancing immunotherapy solutions for cancer treatment. John Stagg is the founder, and the company has engaged in seven deals to date.00 mn.Surface Oncology, Inc. develops a range of cancer immunotherapies designed to harness the body's immune system to combat tumors. Their product offerings include targeted therapies that focus on enhancing immune checkpoint responses, aimed at providing treatment options for various cancer types.In 2022, Surface Oncology, Inc.Looking ahead, Surface Oncology, Inc. aims to expand its product line by developing new immunotherapy treatments scheduled for launch in the coming years. The company is targeting expansion into additional markets in Europe and Asia by 2025.

Who invested in Surface Oncology

6 investors across 2 rounds

See all investors in Surface Oncology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 9, 2015

    Amount

    $24M

    Investors

    Locked

  2. Seed

    Jun 1, 2014

    Amount

    Undisclosed

    Investors

    Locked

Questions about Surface Oncology

Who invested in Surface Oncology?

Surface Oncology has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Surface Oncology raised?

Surface Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Surface Oncology last raise money?

Surface Oncology's most recent round on record is a Series A, in Jan 2015.

What does Surface Oncology do?

Surface Oncology is a pharmaceuticals company.

Where is Surface Oncology headquartered?

Surface Oncology is headquartered in Cambridge, US.

Which VCs invest in companies like Surface Oncology?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Surface Oncology's stage. Their profiles are linked below.

Raising like Surface Oncology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.